Answers are grounded in this paper and cite their sources.
Evidence on the association between the combined triglyceride–glucose and frailty index (TyGFI) and mortality across populations remains limited. We examined this association in two nationally representative cohorts. We analyzed adults aged ≥ 45 years from two nationally representative cohorts: NHANES 1999–2018 ( n = 10,404) and CHARLS 2011 baseline ( n = 8,145). TyGFI was calculated as TyG×FI, and analyzed continuously and by cohort-specific quartiles. Adjusted Cox models assessed all-cause mortality in both cohorts and cardiovascular and cancer mortality in NHANES. Restricted cubic splines examined nonlinearity; subgroup, sensitivity, and exploratory mediation analyses were also performed. Each 1-unit increase in TyGFI was associated with higher all-cause mortality in NHANES (HR 1.60, 95% CI 1.50–1.70) and CHARLS (HR 1.98, 95% CI 1.77–2.22) after covariate adjustment. Corresponding NHANES HRs were 1.70 (95% CI 1.55–1.87) for cardiovascular mortality and 1.34 (95% CI 1.17–1.53) for cancer mortality. Exploratory exposure–response analyses suggested nonlinearity for all-cause and cardiovascular mortality in NHANES, with no clear evidence of nonlinearity for cancer mortality or CHARLS all-cause mortality. Exploratory mediation analyses involving inflammatory markers yielded small estimated indirect proportions (0.4%–3.2%) without establishing causal mediation. Sensitivity analyses supported the overall associations; exploratory interaction tests suggested subgroup differences in NHANES. TyGFI was associated with higher mortality risk after multivariable adjustment in two nationally representative cohorts. Further prospective studies are warranted to assess its potential clinical utility and investigate underlying mechanisms. Not applicable.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: